Results 161 to 170 of about 94,080 (214)
Meningococcemia in a Boy with Dense Deposit Disease Receiving the C5 Complement Inhibitor Ravulizumab: A Case Report. [PDF]
Gonedes AJ +4 more
europepmc +1 more source
Perspective on the pathogenic Neisseria: milestones, challenges, and future directions. [PDF]
Duncan JA +6 more
europepmc +1 more source
Meningitis: is vaccine introduction enough? [PDF]
The Lancet Regional Health-Southeast Asia.
europepmc +1 more source
Strengthening regional surveillance: MenMap Network's year 1 findings on bacterial meningitis in Jordan, Egypt, and Iraq (2023-2024). [PDF]
Al-Kershi L +22 more
europepmc +1 more source
Fulminant Meningococcemia Presenting as Acute Abdomen Without Meningeal Signs: A Report of Two Cases and Review of Atypical Presentations. [PDF]
Nabi A +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Treatment Options in Neurology, 2010
Meningococcal meningitis (MM) is the most common presentation of meningococcal disease and an important cause of morbidity and mortality worldwide. When MM is associated with shock, early recognition and treatment of shock is essential. No investigation should delay starting antibiotics once the diagnosis is suspected. Corticosteroids can be started at
Ricardo G, Branco, Robert C, Tasker
openaire +2 more sources
Meningococcal meningitis (MM) is the most common presentation of meningococcal disease and an important cause of morbidity and mortality worldwide. When MM is associated with shock, early recognition and treatment of shock is essential. No investigation should delay starting antibiotics once the diagnosis is suspected. Corticosteroids can be started at
Ricardo G, Branco, Robert C, Tasker
openaire +2 more sources

